Osteoporosis, and the fractures it causes, is a long term condition that, as yet, has no cure. The main aims of treatment are to prevent further fractures and relieve pain so that patients can continue to live as healthy and active a life as possible.

Doctors will often use a range of different treatments, including oestrogen and calcitonin hormone therapies, calcium and vitamin D supplements and medicines including bisphosphonates and selective oestrogen receptor modulators (SERMs). Roche’s treatment portfolio includes a bisphosphonate for use in osteoporosis. Bisphosphonates are currently the most widely prescribed medicines for osteoporosis and work by slowing down the rate of bone loss.